Introduction:

Establishing cardiovascular risk (CVR) estimators that allow for equal concordance within the subset of the population is important for establishing therapy that provide advantages for each subpopulation. In this article we focus on buying CVR scale in women with type 2 diabetes mellitus.

Objective:

Compare between the Framingham, SCORE/REGICOR and ACC/AHA scales in a court of women with diabetes.

Methods:

The data collected were between 2014 and 2016 from the population of the Caribbean Endocrinological Center, Barranquilla, Colombia, considering the sociodemographic, anthropometric, and clinical variables. In this study, it was possible to establish comparisons between the Framingham, SCORE/REGICOR and ACC/AHA scales to identify cardiovascular risk levels in women with T2DM.

Results:

100% of the sample (n = 107) were women with a mean age of 58.5 ± 13,646 years, 78 (72.9%) were classified as low risk, 23 (21.5%) intermediate and 6 ( 5.6%) high with the scale The SCORE/REGICOR scale showed 61 (57.0%) at low risk, 45 (42.1%) moderate and 1 (0.9%) high; while ACC / AHA 38 (35.5%) is classified as low risk and 69 (64.5%) as high.

Conclusions:

In the present study, a low concordance was observed when comparing the cardiac risk scales (Framingham, SCORE/REGICOR and ACC/AHA) in Colombian women with type two diabetes and it was also observed that age and total cholesterol were the values that more affected variation between the comparative cardiovascular risk scale.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )